*Listed in PDR 2016
Description
ProBionic® contains four strands of live, healthy bacteria that enter the digestive system and help balance bacterial populations in the intestinal tract. This supplement is for individuals with symptoms of poor digestive health such as constipation, diarrhea, bloating, and inflammation.
ProBionic® is a water-soluble, light-pink crystalline powder. The proprietary encapsulation used for ProBionic® allows the healthy bacteria to be delivered to the small intestines alive, ensuring the bacteria can confer health benefits for the user. Each packet of ProBionic® contains a 100 mg Probiotic Blend of Lactobacillus acidophilus LA 02, Lactobacillus rhamnosus LR 04, Bifidobacterium breve BR 03, and Bifidobacterium lactis BS 01, with a total of 5 billion cells. In addition to these live bacteria, each 2 g packet also contains xylitol, natural berry flavor, citric acid, and silica.
Benefits and Research
Your body needs good bacteria to help with detoxification, food digestion, waste removal, production of vitamins, and protection from harmful organisms. When the intestinal bacteria is imbalanced and unhealthy bacteria dominate, the body is less able to fight off infection resulting in inflammation. The individual strains used in ProBionic® are helpful for maintaining overall gut health.
The proprietary encapsulation used in ProBionic® allows healthy strains of bacteria to be delivered to the digestive system alive and undisturbed. This also ensures the bacteria will remain alive throughout their shelf life.
Suggested Use
The contents of the packet can be taken dry, or they can be mixed with 8-10 fl. oz. of liquid (water or juice) and consumed. Use one packet daily
Safety and Warnings
ProBionic® is generally well tolerated. As with any dietary supplement, some gastrointestinal discomfort may be experienced.
How Supplied
ProBionic® is packaged in single-serve foil packets.
References
Saggioro A. Probiotics in the treatment of Irritable Bowel Syndrome. Journal of Clinical Gastroenterology, 2004; 38(8): S104-106.
Del Piano M, Carmagnola S, Andorno S, Pagliarulo M, Tari R, Mogna L, Strozzi GP, Sforza F, Capurso L. Evaluation of the intestinal colonization by microencapsulated probiotic bacteria in comparison to the same uncoated strains. Under pubblication in supplement of the Journal of Clinical Gastroenterology.
Del Piano M, Carmagnola S, Anderloni A, Andorno S, Ballare M, Balzarini M, Montino F, Orsello M, Pagliarulo M, Stratori M, Tari R, Sforza F, Capurso L. The use of probiotics in healthy volunteers with evacuation disorders and hard stools. A double blind, randomized, placebo-controlled study. Under pubblication in a supplement of the Journal of Clinical Gastroenterology.
Pregliasco F., Anselmi G., Fonte L., Giussani F., Schieppati S., Soletti L. A New Chance of Preventing Winter Diseases by the Administration of Symbiotic Formulations. Journal of Clinical Gastroenterology, 2008; 42(2): 224-233.
*THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE.